Telomir Pharmaceuticals 2024 Investor Presentation

Telomir Pharmaceuticals is a preclinical-stage biotech company developing TELOMIR-1, a novel small molecule designed to lengthen DNA telomeres for age reversal and age-related inflammatory disease treatment. The presentation outlines the company's technology platform and development strategy as of August 2024.